Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

Diffuse large B-cell lymphoma can be classified by gene expression profiling into germinal center and activated B-cell subtypes with different prognoses after rituximab-CHOP. The importance of previously recognized prognostic markers, such as Bcl-2 protein expression and BCL2 gene abnormalities, has...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Visco, Carlo, Tzankov, Alexander, Xu-Monette, Zijun Y., Miranda, Roberto N., Tai, Yu Chuan, Li, Yan, Liu, Wei-min, d'Amore, Emanuele S. G., Li, Yong, Montes-Moreno, Santiago, Dybkær, Karen, Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Wang, Huan-You, Dunphy, Cherie H., His, Eric D., Zhao, X. Frank, Choi, William WL., Zhao, Xiaoying, van Krieken, J. Han, Huang, Qin, Ai, Weiyun, O'Neill, Stacey, Ponzoni, Maurilio, Ferreri, Andres JM., Kahl, Brad S., Winter, Jane N., Go, Ronald S., Dirnhofer, Stephan, Piris, Miguel A., Møller, Michael B., Wu, Lin, Medeiros, L. Jeffrey, Young, Ken H.
פורמט: Artigo
שפה:Inglês
יצא לאור: Ferrata Storti Foundation 2013
נושאים:
Articles
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3561433/
https://ncbi.nlm.nih.gov/pubmed/22929980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2012.066209
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים